Analyst Price Targets — AVNS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 30, 2024 3:10 pm | Rick Wise | Stifel Nicolaus | $20.00 | $18.58 | StreetInsider | Avanos Medical (AVNS) PT Lowered to $20 at Stifel |
| January 6, 2023 8:50 am | — | Morgan Stanley | $26.00 | $26.99 | Benzinga | Morgan Stanley Maintains Underweight on Avanos Medical, Raises Price Target to $26 |
| July 18, 2022 9:35 am | — | Stifel Nicolaus | $28.00 | $26.89 | Benzinga | Stifel Maintains Hold on Avanos Medical, Lowers Price Target to $28 |
| July 15, 2022 9:38 am | — | Morgan Stanley | $28.00 | $27.19 | Benzinga | Morgan Stanley Maintains Underweight on Avanos Medical, Lowers Price Target to $28 |
| May 5, 2022 7:56 am | — | Morgan Stanley | $33.00 | $29.29 | Benzinga | Morgan Stanley Maintains Underweight on Avanos Medical, Lowers Price Target to $33 |
Latest News for AVNS
BlackRock Inc. purchased a new position in Avanos Medical, Inc. (NYSE: AVNS) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 7,468,794 shares of the company's stock, valued at approximately $185,824,000. BlackRock Inc. owned 15.94% of Avanos Medical at the end of
NEW YORK--(BUSINESS WIRE)--Sterlington advises Avanos Medical management team on $1.27 billion acquisition.
ALPHARETTA, Ga., July 22, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos" or the "Company"), a leading medical technology company, today announced that its stockholders have voted to approve the pending acquisition of Avanos by affiliates of investment funds advised by American Industrial Partners ("AIP") at a special meeting of stockholders (the "Special Meeting") held earlier today.
NEW YORK, July 20, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600
ALPHARETTA, Ga. and NEW YORK, July 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos") and American Industrial Partners ("AIP") jointly announced the receipt of all required regulatory approvals to complete the pending acquisition of Avanos by affiliates of investment funds advised by AIP (the "Merger").
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AVNS.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.